RELAFEN 750 (Relafen 750 mg)
Generic Name: nabumetone
Pill imprint RELAFEN 750 has been identified as Relafen 750 mg.
Relafen is used in the treatment of osteoarthritis; rheumatoid arthritis; sciatica; muscle pain; frozen shoulder (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Relafen 750 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for RELAFEN 750 (Relafen 750 mg)
Relafen
- Generic Name:
- nabumetone
- Imprint:
-
RELAFEN
750 - Strength:
- 750 mg
- Color:
- Beige
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00029-4852
- Inactive Ingredients:
- hypromellose
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium lauryl sulfate
sodium starch glycolate
titanium dioxide
ferric oxide
More resources
Relafen is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
